Literature DB >> 9433781

Synthesis and antitumor activity of fused quinoline derivatives. V. Methylindolo[3,2-b]quinolines.

Y Takeuchi1, M Kitaomo, M R Chang, S Shirasaka, C Shimamura, Y Okuno, M Yamato, T Harayama.   

Abstract

Indolo[3,2-b]quinoline derivatives (1b-i) with a methyl group at each possible position have been synthesized. The 1-methyl (1b) and 9-methyl (1i) derivatives were inactive, but the 3-methyl (1d), 4-methyl (1e), and 6-methyl (1f) derivatives exhibited high treatment/control (T/C) value and cure rates against leukemia P388 in mice. These results indicated that modification of indolo[3,2-b]quinoline derivatives at 3, 4, and 6 positions may be useful approach for lead optimization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9433781     DOI: 10.1248/cpb.45.2096

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter.

Authors:  Peda V L Boddupally; Seongmin Hahn; Cristina Beman; Biswanath De; Tracy A Brooks; Vijay Gokhale; Laurence H Hurley
Journal:  J Med Chem       Date:  2012-06-25       Impact factor: 7.446

2.  3-[4-(10H-Indolo[3,2-b]quinolin-11-yl)piperazin-1-yl]propan-1-ol.

Authors:  Gary S Nichol; Peda V L Boddupally; Biswanath De; Laurence H Hurley
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.